Evolent Health, Inc.
—- Market cap
- —
- Debt
- +$1.14B
- Cash
- −$196.20M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: EVH stock price vs CTMX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTMX's multiple
Needs CTMX P/S.
Implied fair value · at EVH's multiple
Needs EVH P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EVH FY 2025 (ended Dec 31, 2025) · CTMX FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Evolent Health, Inc. · implied price per share
Bear
-$38.04
Base
-$44.75
Bull
-$51.46
CytomX Therapeutics, Inc. · implied price per share
Bear
$0.44
Base
$0.52
Bull
$0.60
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
2.75x
0.03x
Net debt / EBITDA
Leverage against operating earnings
-2.89x
20.51x
Cash and equivalents
Liquid reserves on the balance sheet
$196.20M
$292.06M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cigna Group
EVH vs CI
MOLINA HEALTHCARE, INC.
EVH vs MOH
Teladoc Health, Inc.
EVH vs TDOC
CLOVER HEALTH INVESTMENTS, CORP. /DE
EVH vs CLOV
UNITEDHEALTH GROUP INC
EVH vs UNH
IDEAYA Biosciences, Inc.
EVH vs IDYA
EXELIXIS, INC.
EVH vs EXEL
GILEAD SCIENCES, INC.
EVH vs GILD
AMGEN INC
EVH vs AMGN
AbbVie Inc.
EVH vs ABBV
BRISTOL MYERS SQUIBB CO
EVH vs BMY
$1.14B
$2.99M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.